Class 4 Medicines Defect Notification: Fexofenadine Hydrochloride 120mg film-coated tablets, Chanelle Medical Unlimited Company
- The problem
- Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on certain batches of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
DMRC reference number
DMRC – 36081293
Marketing Authorisation Holder
Chanelle Medical Unlimited Company
Medicine Details
Fexofenadine Hydrochloride 120mg film-coated tablets
Licence: PL: 13931/0039
Active ingredient: Fexofenadine Hydrochloride
SNOMED code: 14161911000001109
GTIN: 5099299199583
Affected Lot Batch Numbers
| Batch No. | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| HM11123A | 28/02/2026 | 30’s | 20/09/2023 |
| HM10523 | 28/02/2026 | 30’s | 29/08/2024 |
| HM10623 | 28/02/2026 | 30’s | 19/09/2024 |
| HM10723A | 28/02/2026 | 30’s | 19/09/2024 |
| HM10823 | 28/02/2026 | 30’s | 31/10/2024 |
| HM10923 | 28/02/2026 | 30’s | 15/01/2025 |
| HM11023 | 28/02/2026 | 30’s | 31/01/2025 |
| HM11223 | 28/02/2026 | 30’s | 11/02/2025 |
| HM11323 | 28/02/2026 | 30’s | 17/02/2025 |
| HM11423 | 28/02/2026 | 30’s | 25/02/2025 |
| HM11623 | 28/02/2026 | 30’s | 25/02/2025 |
| HM11523A | 31/03/2026 | 30’s | 25/02/2025 |
| HM11723 | 31/03/2026 | 30’s | 11/03/2025 |
| HM11823 | 31/03/2026 | 30’s | 31/03/2025 |
| HM11923 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12023 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12123 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12223 | 31/03/2026 | 30’s | 02/04/2025 |
| HM12323A | 31/03/2026 | 30’s | 02/04/2025 |
| HM12423 | 31/03/2026 | 30’s | 08/04/2025 |
| HM12523 | 31/03/2026 | 30’s | 24/04/2025 |
| HM12623 | 31/03/2026 | 30’s | 30/04/2025 |
| HM12723 | 30/04/2026 | 30’s | 16/04/2025 |
| HM12823 | 30/04/2026 | 30’s | 20/05/2025 |
| HM12923 | 30/04/2026 | 30’s | 11/06/2025 |
| HM13023 | 30/04/2026 | 30’s | 13/06/2025 |
Background
Chanelle Medical Unlimited Company has informed the MHRA of an error with the
European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on the
cartons of the above batch of Fexofenadine Hydrochloride 120mg film-coated tablets,
distributed by Healthcare Pharma Limited. When scanned, the EAN/GTIN barcode
identifies the product as Naratriptan 2.5mg Tablets.
The other product details on the carton, including the name, strength and pharmaceutical
form of the medicine are correct. The quality of the medicine is not impacted by the
labelling defect.
Advice for Healthcare Professionals:
Healthcare professionals are advised to use caution and consider extra safeguards for
these batches in robotic or automated dispensing system or stocking systems and
should carry out manual dispensing and stocking, as appropriate.
The product quality of the Fexofenadine Hydrochloride 120mg film-coated tablets is not
impacted by this issue, therefore the affected batches are not being recalled.
All remaining stock of Naratriptan 2.5mg Tablets which has not been distributed from UK
wholesaler will be placed on hold until April 2026 (Last expiry of impacted Fexofenadine
stock) to provide further mitigation that the wrong product may be selected.
Advice for Patients:
No action is needed from patients, continue to take medication from these batches as
prescribed by your healthcare professional. The issue is related to the wrong barcode on
the cartons of the listed batch of Fexofenadine Hydrochloride 120mg film-coated tablets
and will be controlled by the healthcare professionals prescribing/dispensing the
medication. The quality of the medication is not affected. Patients who experience
adverse reactions or have any questions about their medication should seek medical
attention. Any suspected adverse reactions should also be reported via the MHRA
Yellow Card scheme.
Additional information:
For all medical information enquiries and information on this product, please contact
Medical Information Department chanelle@medinformation.co.uk or telephone +44 808
304 2429 (Toll free-UK). For stock control enquiries please email David Hammond:
david.hammond@healthcarepharma.co.uk.
Recipients of this Medicines Recall should bring
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document
Updated 21 August 2025. This page summarises an official notice. Details can change – always follow the official notice.